{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:51:28Z","timestamp":1757451088448},"reference-count":16,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.3960\/jslrt.19038","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T22:05:43Z","timestamp":1585346743000},"page":"11-16","source":"Crossref","is-referenced-by-count":9,"title":["Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer"],"prefix":"10.3960","volume":"60","author":[{"given":"Keiichi","family":"Moriya","sequence":"first","affiliation":[{"name":"Department of Hematology, Shinmatsudo Central General Hospital, Matsudo, Japan,"},{"name":"Department of Pathology, Tokai University School of Medicine, Isehara, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara Yukie","family":"Kikuti","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine, Isehara, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Carreras","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine, Isehara, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine, Isehara, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Shiraiwa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine, Isehara, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Gaulard P, Swerdlow SH, Harris NL, Sundstr\u00f6m C, Jaffe ES. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, <i>et al<\/i>. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed, Lyon, World Health Organization. 2017; pp. 462-464."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Sato Y. Highlights: focus on immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop. 2019; 59: 46-47.","DOI":"10.3960\/jslrt.19020"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Huwait H, Wang B, Shustik C, Michel RP. Composite cutaneous lymphoma in a patient with rheumatoid arthritis treated with methotrexate. Am J Dermatopathol. 2010; 32: 65-70.","DOI":"10.1097\/DAD.0b013e3181af7dee"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ichikawa A, Arakawa F, Kiyasu J <i>et al.<\/i> Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013; 91: 20-28.","DOI":"10.1111\/ejh.12116"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Makis W, Ciarallo A, Wang B, Gonzalez-Verdecia M, Probst S. Composite cutaneous lymphoma (iatrogenic immunodeficiency-associated lymphoproliferative disorder) in a patient with rheumatoid arthritis treated with methotrexate: staging and evaluation of response to therapy with 18F-FDG PET\/CT. Nucl Med Mol Imaging. 2017; 51: 261-265.","DOI":"10.1007\/s13139-016-0463-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Br\u00e4uninger A, Spieker T, Willenbrock K <i>et al.<\/i> Survival and clonal expansion of mutating \u201cforbidden\u201d (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma. J Exp Med. 2001; 194: 927-940.","DOI":"10.1084\/jem.194.7.927"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Ikeda J, Morii E, Tomita Y <i>et al.<\/i> Methotrexate-associated lymphoproliferative disorder mimicking composite lymphoma. Int J Hematol. 2006; 83: 363-365.","DOI":"10.1532\/IJH97.05181"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ikeda T, Gion Y, Yoshino T, Sato Y. A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspects. J Clin Exp Hematop. 2019; 59: 64-71.","DOI":"10.3960\/jslrt.18039"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Tokuhira M, Tamaru J, Kizaki M. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop. 2019; 59: 72-92.","DOI":"10.3960\/jslrt.19007"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Gion Y, Iwaki N, Takata K <i>et al.<\/i> Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci. 2017; 108: 1271-1280.","DOI":"10.1111\/cas.13249"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Saito S, Suzuki K, Yoshimoto K <i>et al.<\/i> Restoration of decreased T helper 1 and CD8+ T Cell subsets is associated with regression of lymphoproliferative disorders developed during methotrexate treatment. Front Immunol. 2018; 9: 621.","DOI":"10.3389\/fimmu.2018.00621"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Inui Y, Matsuoka H, Yakushijin K <i>et al.<\/i> Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leuk Lymphoma. 2015; 56: 3045-3051.","DOI":"10.3109\/10428194.2015.1022769"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Tokuhira M, Saito S, Okuyama A <i>et al.<\/i> Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. Leuk Lymphoma. 2018; 59: 1143-1152.","DOI":"10.1080\/10428194.2017.1369073"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Goyal G, Nguyen AH, Kendric K, Caponetti GC. Composite lymphoma with diffuse large B-cell lymphoma and classical Hodgkin lymphoma components: A case report and review of the literature. Pathol Res Pract. 2016; 212: 1179-1190.","DOI":"10.1016\/j.prp.2016.11.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Berti A, Felicetti M, Peccatori S <i>et al.<\/i> EBV-induced lymphoproliferative disorders in rheumatic patients: A systematic review of the literature. Joint Bone Spine. 2018; 85: 35-40.","DOI":"10.1016\/j.jbspin.2017.01.006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Miranda RN, Loo E, Medeiros LJ. Iatrogenic immunodeficiency-associated classical hodgkin lymphoma: clinicopathologic features of 54 cases reported in the literature. Am J Surg Pathol. 2013; 37: 1895-1897.","DOI":"10.1097\/PAS.0000000000000095"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/1\/60_19038\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T04:02:08Z","timestamp":1585368128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/1\/60_19038\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.19038","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}